Oncogene-specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (51)
The Hallmarks of Cancer
2000 • 27,569 citations
CDK inhibitors: positive and negative regulators of G1-phase progression
1999 • 6,003 citations
Cancer Cell Cycles
1996 • 5,379 citations
The retinoblastoma protein and cell cycle control
1995 • 4,873 citations
The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor
1997 • 3,702 citations
Mitochondrial Diseases in Man and Mouse
1999 • 3,008 citations
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
1999 • 1,650 citations
Molecular pathogenesis of human hepatocellular carcinoma
2002 • 1,424 citations
Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes
2003 • 1,350 citations
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
1997 • 1,015 citations
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling
2004 • 874 citations
TRB3: A tribbles Homolog That Inhibits Akt/PKB Activation by Insulin in Liver
2003 • 809 citations
E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis
2001 • 747 citations
Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass
2003 • 733 citations
Drosophila myc Regulates Cellular Growth during Development
1999 • 637 citations
Role for E2F in Control of Both DNA Replication and Mitotic Functions as Revealed from DNA Microarray Analysis
2001 • 587 citations
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
2004 • 573 citations
Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes
2003 • 525 citations
Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes
2003 • 509 citations
An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets
2003 • 481 citations
Application of comparative functional genomics to identify best-fit mouse models to study human cancer
2004 • 461 citations
Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis
2002 • 449 citations
PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP
2005 • 424 citations
Regulation of Peroxisome Proliferator-Activated Receptor γ Expression by Adipocyte Differentiation and Determination Factor 1/Sterol Regulatory Element Binding Protein 1: Implications for Adipocyte Differentiation and Metabolism
1999 • 424 citations
Obesity and hepatocellular carcinoma
2004 • 393 citations
Proliferation, But Not Growth, Blocked by Conditional Deletion of 40 S Ribosomal Protein S6
2000 • 366 citations
c-Myc enhances protein synthesis and cell size during B lymphocyte development
1999 • 357 citations
E2Fs Regulate Adipocyte Differentiation
2002 • 310 citations
Analysis of genomic targets reveals complex functions of MYC
2004 • 296 citations
Coordinated regulation of life and death by RB
2003 • 290 citations
E2F1 and c-Myc Potentiate Apoptosis through Inhibition of NF-κB Activity that Facilitates MnSOD-Mediated ROS Elimination
2002 • 282 citations
Myc Requires Distinct E2F Activities to Induce S Phase and Apoptosis
2001 • 253 citations
Specific Cleavage of Mcl-1 by Caspase-3 in Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis in Jurkat Leukemia T Cells
2005 • 252 citations
Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.
1993 • 237 citations
Targets and mechanisms for the regulation of translation in malignant transformation
2004 • 219 citations
Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo
2000 • 188 citations
E2F1 and c-Myc in Cell Growth and Death
2003 • 169 citations
The identification of E2F1-specific target genes
2002 • 148 citations
Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis
2000 • 148 citations
SINK Is a p65-interacting Negative Regulator of NF-κB-dependent Transcription
2003 • 107 citations
Transcriptional Regulation of AKT Activation by E2F
2004 • 106 citations
Disruption of β-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice
2004 • 99 citations
The hypocholesterolemic agent LY295427 up-regulates INSIG-1, identifying the INSIG-1 protein as a mediator of cholesterol homeostasis through SREBP
2002 • 75 citations
Secreted Site-1 Protease Cleaves Peptides Corresponding to Luminal Loop of Sterol Regulatory Element-binding Proteins
1999 • 74 citations
Bcr-Abl-Mediated Protection from Apoptosis Downstream of Mitochondrial Cytochrome c Release
2004 • 58 citations
Antisense Depletion of Death-associated Protein Kinase Promotes Apoptosis
2003 • 47 citations
Regulation of the cell cycle in response to inhibition of mitochondrial generated energy
2005 • 44 citations
MAT1-Modulated CAK Activity Regulates Cell Cycle G1 Exit
2001 • 32 citations
Altered gene expression in acute systemic inflammation detected by complete coverage of the human liver transcriptome
2004 • 31 citations
Diabetes and hepatocellular carcinoma: Associations, biologic plausibility, and clinical implications
2005 • 22 citations
Genome-wide response of the human Hep3B hepatoma cell to proinflammatory cytokines, from transcription to translation
2005 • 15 citations